Loading clinical trials...
Loading clinical trials...
An exploratory investigation of gain precalculation principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These gain precalculation principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and assess strength and weaknesses of these gain precalculation principles in terms of speech intelligibility to determine their application in hearing instruments (Phase of development). Objective laboratory measurements as well as subjective ratings will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono centric at Sonova AG Headquarter based in Stäfa.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
No
Sonova AG
Stäfa, Switzerland
Start Date
March 20, 2026
Primary Completion Date
April 30, 2026
Completion Date
April 30, 2026
Last Updated
February 5, 2026
16
ESTIMATED participants
Competitor device, hearing aid with standard gain precalculation principle
DEVICE
Hearing aid with gain precalculation principle 1
DEVICE
Hearing aid with gain precalculation principle 2
DEVICE
Lead Sponsor
Sebastian Griepentrog
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07222202